BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 1999
View Archived Issues
New treatment strategy successful in patients with severe CHF
Read More
Cancer therapeutics joint venture IBC Pharmaceuticals receives start-up funding
Read More
Toprol-XL effective in heart failure; MERIT-HF trial results presented
Read More
Long-term treatment with phen-fen associated with valvular abnormalities
Read More
Eptifibatide lowers MI incidence, heart muscle injury in ACS patients
Read More
Telomeres and telomerase linked to cancer, age-related changes
Read More
Pliva and Althexis collaborate on structure-based design of new antibiotics
Read More
New DAG analogues acting as PKC agonists or antagonists
Read More
Zeria patents new series for BPH
Read More
New patent issues covering Cytoclonal's novel methods of producing paclitaxel
Read More
Orally active analgesic agents in development at Otsuka
Read More
N-type calcium channel inhibitors described by Ono
Read More
GABA-A receptor ligands from MS&D for Alzheimer's disease
Read More
Volunteer study suggests that CMI-977 may be superior to zileuton in both efficacy and safety
Read More
New market introduction for Seretide
Read More
Kanebo's Na+/H+ exchange inhibitor is a promising treatment for acute coronary syndrome
Read More
Venous responsiveness to NE is enhanced in the presence of aspirin
Read More
BTG licenses anti-CD3 antibody to LeukoSite
Read More
Health Canada approves Rebetron for chronic HCV
Read More
FDA grants priority review status, sets date for advisory committee review of Actos
Read More
Spanish market introduction announced for antirejection MAb
Read More
SkyePharma completes DepoTech acquisition
Read More
Hollis-Eden to initiate HIV/AIDS trials with HE-2000 in South Africa
Read More
Improvement in seasonal allergic rhinitis following preventive treatment with rhuMAb-E25
Read More
Effexor XR receives FDA approval for treatment of GAD
Read More
CysLT1 antagonists show potential as Rx for chronic urticaria
Read More
Hemosol to begin multinational phase III trials of Hemolink
Read More